Quality of Life Outcomes (Posters)

Friday, May 29, 2015: 12:00 PM-2:00 PM
Griffin Hall
Physical Activity, Dietary Sodium, and Smoking As Correlates of Walking Performance in Persons with MS
Julia M Balto, BSc, University of Illinois at Urbana-Champaign; Jennifer L Barnes, Ph.D., R.D., L.D.N., University of Illinois at Urbana-Champaign; Ipek Ensari, M.Ed, University of Illinois Urbana-Champaign; Elizabeth A Hubbard, MSc, University of Illinois at Urbana-Champaign; Robert W Motl, PhD, University of Illinois at Urbana Champaign

Baseline Characteristics of Patients Enrolled in the Teri-PRO Phase 4 Study in the United States Vs Canada, Europe, and Latin America
Patricia K Coyle, MD, Stony Brook University Medical Center; Christopher LaGanke, MD, North Central Neurology Associates; Bhupendra Khatri, MD, The Regional MS Center, Center for Neurological Disorders at Wheaton Franciscan Healthcare; Ralf Gold, MD, St. Josef-Hospital/Ruhr-University Bochum; Steven Cavalier, MD, Genzyme, a Sanofi company; Sandrine Brette, MSc, Lincoln; Francesca Baldinetti, MD, Genzyme, a Sanofi company; Keith R Edwards, MD, FAAN, Multiple Sclerosis Center of Northeastern New York

Physician Rating of Fitness-to-Drive in Multiple Sclerosis
Hannes Devos, PhD, Georgia Regents University; Abiodun E Akinwuntan, PhD, MPH, Georgia Regents University; Maud Ranchet, PhD, Georgia Regents University; Mark Tant, PhD, Belgian Road Safety Institute

Hair Photography Project: Exploring the Clinical Course of Hair Thinning Associated with Teriflunomide
Keith R Edwards, MD, FAAN, Multiple Sclerosis Center of Northeastern New York; Lori Hendin Travis, MD, Phoenix Neurological Associates Ltd; Annette Okai, MD, Multiple Sclerosis Treatment Center of Dallas; Scott Jackson, MD, Baton Rouge Clinic; Lisa Farnett, PharmD, Genzyme, a Sanofi company; Steven Cavalier, MD, Genzyme, a Sanofi company; Darren Stam, PharmD, Genzyme, a Sanofi company; Ken Liu, PharmD, Genzyme, a Sanofi company
Tanner Health Miles: Walking and Talking MS
Tracy Flemming Tracy, OTR/L, MSCS, MSSMC, Tanner Center for MS; Virgina R Weinacker, DPT, Tanner Center for MS; Emily S Riser, MD, Tanner Center for MS; Bess Martin, PT, MSCS, Tanner Center for MS
Association Between Measures of Disability and Employment in Secondary Progressive Multiple Sclerosis: Baseline Data from the ASCEND Natalizumab Trial
Myla D Goldman, MD, Msc, University of Virginia; Diego Cadavid, MD, Biogen Idec; Carmen Castrillo, MD, Biogen Idec; Yun Chen, PhD, Biogen Idec; Qunming Dong, PhD, Biogen Idec; Crystal Watson, MS, Biogen Idec; Deb Steiner, MD, MS, Biogen Idec; Daniel Mikol, MD, PhD, Biogen Idec; Aaron E Miller, MD, Icahn School of Medicine at Mount Sinai, The Corinne Goldsmith Dickinson Center for Multiple Sclerosis
The Effects of Multiple Sclerosis on Daily Money Management Activities
Shannon L Haas, MS, Kessler Foundation; John DeLuca, Ph.D., Kessler Foundation; Yael Goverover, PhD, OT, New York Univeristy

To What Extent Does JC Virus Status Influence Patient Decisions Regarding Treatment with Natalizumab?
William Lusher, RGN, Salford Royal NHS Trust; Nina Jennings, BSc, RGN, Salford Royal NHS Trust; Karen Vernon, BSc (hons). RGN., Salford Royal NHS Trust; David Rog, MD, MRCP (UK), Salford Royal NHS Trust; Paul Talbot, MB ChB MD FRCP, Salford Royal NHS Trust
The Impact of Relapse on Productivity, Costs, and Resource Utilization in Multiple Sclerosis: A Retrospective U.S. Database Analysis
John J Ko, PharmD, MS, The University of Texas at Austin; Juzer Lotya, MSc. Statistics, Novartis Dublin Business Solution Centre Global Business Services; Caitriona ONeill, MPSI, MBA, PhD, Novartis Dublin Business Solution Centre Global Business Services; Tara A Nazareth, MPH, Novartis Pharmaceuticals Corporation; Rahul Sasane, PhD, Novartis Pharmaceuticals Corporation

Living Your Best Life with MS? Examination of the National MS Society's Everyday Matters Program
Kimberly Koch, MPA, National Multiple Sclerosis Society; Sara Anne Tompkins, Ph.D., Madipen, LLC

Ballroom Dance for Persons with MS: Prelimiary Efficacy
Alexander V Ng, Ph.D., Marquette University; Sheri L Bunyan, MPT, ATC, Concordia University; Jimin Suh, BS, Marquette University; Tyler J Gregory, BS, Marquette University; Shannon Gambon, BS, Marquette University; Lauren Kalita, BS, Marquette University

A Comprehensive Revision of the Incapacity Status Scale: ISS-2
Jeffrey G Portnoy, B.A., Yeshiva University; Marnina B Stimmel, B.A., Yeshiva University; Sara Flood, M.A., Yeshiva University; Gabriel Hoffnung, M.A., Yeshiva University; Mary Ann Picone, M.D., Holy Name Medical Center; Lisa Glukhovsky, B.A., Yeshiva University; Jessica H Sloan, B.A., Yeshiva University; Roseann Archetti, B.S., Yeshiva University; Eliana Pasternak, B.A., Yeshiva University; Jason Botvinick, B.A., Yeshiva University; Elana Mendelowitz, B.A., Yeshiva University; Frederick W Foley, Ph.D., Holy Name Medical Center
MS in US Minorities: Results of a Research Study Designed to Understand Educational Needs of Hispanic and African American Patients with MS
Gregory D Salinas, PhD, CE Outcomes, LLC; Brandon Coleman, BS, CE Outcomes, LLC; Eleana Hardy, BA, Biogen Idec; Leslie Meltzer, PhD, Biogen Idec

Iconquerms: A Patient-Powered Research Network for Multiple Sclerosis
Hollie Schmidt, MS, Accelerated Cure for MS; Robert N. McBurney, PhD, Accelerated Cure for MS; Sara Loud, MSEE, MBA, Accelerated Cure for MS; Revere P Kinkel, MD, University of California San Diego

Multiple Sclerosis (MS) Patient Adherence to Delayed-Release Dimethyl Fumarate and Patient Reported Side Effects from a Specialty Pharmacy Program
Terrie Livingston, PharmD, Biogen Idec Inc.; Brieana Bukley, PharmD, Biogen Idec Inc.; Francis Staskon, PhD, Walgreen, Co.; Mark Matusik, PharmD, Walgreen, Co.; Janeen DuChane, PhD, Walgreen, Co.
Connected CareSM for Multiple Sclerosis (MS): Improving Adherence with Managed Therapy for Patients with Indications of Fatigue or Depression
Francis Staskon, PhD, Walgreen, Co.; Rick T Miller, RPh, Walgreen, Co.; Janeen DuChane, PhD, Walgreen, Co.; Mark Matusik, PharmD, Walgreen, Co.
Perceptions about MS Among Hispanic Americans: Need for Targeted Messaging
Lilyana Amezcua, MD, University of Southern California; Ana Palomeque, BS, University of Southern California; Jose Aparicio, CCRP, University of Southern California; Leslie Tarlow, MSN, MSCN, University of Southern California; Annette M Langer-Gould, MD, PhD, Kaiser Permanente, Southern California


Employment Register of Patients on Natalizumab
Catherine B Wingrove, MA Specialist Nurse, Sunderland Royal Hospital
See more of: Poster